Benjamin Haefliger
Zug, ZG 6300, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in Europe.
Journal: Future oncology (London, England)
Published: September 14, 2023
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice.
Journal: HemaSphere
Published: July 06, 2022
Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice.
Journal: Haematologica
Published: December 14, 2021
Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry.
Journal: Cancers
Published: September 20, 2021
Model-guided combinatorial optimization of complex synthetic gene networks.
Journal: Molecular systems biology
Published: December 30, 2016
Precision multidimensional assay for high-throughput microRNA drug discovery.
Journal: Nature communications
Published: August 18, 2015
Highly modular bow-tie gene circuits with programmable dynamic behaviour.
Journal: Nature communications
Published: December 24, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026